Bristol Myers Squibb to Participate in the Guggenheim Healthcare Talks 2023 Oncology Conference
February 03 2023 - 6:59AM
Business Wire
Bristol Myers Squibb (NYSE: BMY) today announced that the
company will take part in a fireside chat at the Guggenheim
Healthcare Talks 2023 Oncology Conference on Thursday, February 9,
2023. Chris Boerner, Ph.D., Executive Vice President, Chief
Commercialization Officer, will answer questions about the company
at 1:00 p.m. ET.
Investors and the general public are invited to listen to a live
webcast of the session at http://investor.bms.com. An archived
edition of the session will be available later that day.
About Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company whose
mission is to discover, develop and deliver innovative medicines
that help patients prevail over serious diseases. For more
information about Bristol Myers Squibb, visit us at BMS.com or
follow us on LinkedIn, Twitter, YouTube, Facebook, and
Instagram.
corporatefinancial-news
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230203005046/en/
Bristol Myers Squibb
Media: media@bms.com
Investor Relations: investor.relations@bms.com
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Apr 2023 to Apr 2024